[Table/Fig-2]:
Symptom prevalence in the euthyroid and hypothyroid groups Note: NS: not significant
| Euthyroid group (TSH 0.39-6.16 μIU/ml) | Hypothyroid group (TSH ≥ 6.17 μIU/ml) | P-value | OR (95% CI) | |
|---|---|---|---|---|
| Symptoms | ||||
| Fatigue | 16/45 (35.6%) | 10/17 (58.8%) | NS | 2.59 (0.82-8.12) |
| Cold intolerance | 2/45 (4.4%) | 10/17 (58.8%) | <0.0001 | 30.71 (5.52-170.76) |
| Constipation | 13/45 (28.9%) | 10/17 (58.8%) | <0.05 | 3.52 (1.10-11.23) |
| Dry skin | 16/45 (35.6%) | 12/17 (70.6%) | <0.01 | 4.35 (1.30-14.57) |
| Tingling sensation | 4/45 (8.9%) | 9/17 (52.9%) | <0.001 | 11.53 (2.84-46.78) |
| Poor concentration/memory | 8/45 (17.8%) | 5/17 (29.4%) | NS | 1.93 (0.53-7.02) |
| Muscle pain/muscle weakness | 10/45 (22.2%) | 8/17 (47.1%) | <0.05 | 3.11 (0.95-10.16) |
| Anxiety/Depression | 9/45 (20.0%) | 5/17 (29.4%) | NS | 1.66 (0.47-5.9) |
| Hair loss | 3/45 (6.7%) | 1/17 (5.9%) | NS | 0.875 (0.08-9.04) |
| Signs | ||||
| Periorbital odema | 7/45 (15.6%) | 13/17 (76.5%) | <0.0001 | 17.64 (4.44-70.16) |
| Pericardial effusion | 7/45 (15.6%) | 9/17 (52.9%) | <0.01 | 6.11 (1.75-21.27) |
| Pleural effusion | 3/45 (6.7%) | 9/17 (52.9%) | <0.001 | 15.75 (3.48-71.27) |
| Ascites | 6/45 (13.3%) | 7/17 (41.2%) | <0.05 | 4.55 (1.25-16.57) |